title: [How important is dipyridamole in patients with ischemic heart disease?].
abstract: Dipyridamol does not have a proven, clinically significant antithrombotic effect. Treatment is relatively expensive. Dipyridamol can cause ischaemia of the heart muscle in patients with ischaemic heart disease. Dipyridamol administration as part of antithrombotic treatment should therefore be selective. Large does can be used as a supplementary loading test for detection of the ischaemic focus.
authors.affiliation: III. interní klinika fakultní nemocnice 2 s fakultnĭ poliklinikou UNZ NV hl. m. Prahy.
authors.forename: J
authors.initials: J
authors.lastname: Spácil
mesh_terms: D003327:Coronary Disease / Q000188:drug therapy*; D004176:Dipyridamole / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D013927:Thrombosis / Q000517:prevention & control
chemical_list: D004176:Dipyridamole
vernacular_title: Jaký má dipyridamol význam u nemocných s ischemickou chorobou srdecní?